Susquehanna International Group’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-32,000
| Closed | -$606K | – | 13994 |
|
|
2025
Q4 | $606K | Sell |
32,000
-10,800
| -25% | -$200K | ﹤0.01% | 8352 |
|
|
2025
Q3 | $798K | Buy |
42,800
+4,000
| +10% | +$74.7K | ﹤0.01% | 7873 |
|
|
2025
Q2 | $715K | Sell |
38,800
-32,200
| -45% | -$571K | ﹤0.01% | 8306 |
|
|
2025
Q1 | $1.24M | Buy |
71,000
+23,200
| +49% | +$391K | ﹤0.01% | 6713 |
|
|
2024
Q4 | $828K | Sell |
47,800
-33,700
| -41% | -$615K | ﹤0.01% | 7434 |
|
|
2024
Q3 | $1.56M | Sell |
81,500
-78,200
| -49% | -$1.32M | ﹤0.01% | 5806 |
|
|
2024
Q2 | $2.46M | Buy |
159,700
+36,200
| +29% | +$517K | ﹤0.01% | 4685 |
|
|
2024
Q1 | $1.82M | Sell |
123,500
-12,600
| -9% | -$174K | ﹤0.01% | 5549 |
|
|
2023
Q4 | $1.94M | Buy |
136,100
+28,500
| +26% | +$405K | ﹤0.01% | 5420 |
|
|
2023
Q3 | $1.5M | Buy |
107,600
+76,200
| +243% | +$975K | ﹤0.01% | 5742 |
|
|
2023
Q2 | $370K | Sell |
31,400
-59,200
| -65% | -$674K | ﹤0.01% | 9014 |
|
|
2023
Q1 | $1.04M | Sell |
90,600
-7,900
| -8% | -$97.7K | ﹤0.01% | 6713 |
|
|
2022
Q4 | $1.23M | Sell |
98,500
-58,600
| -37% | -$747K | ﹤0.01% | 5740 |
|
|
2022
Q3 | $2.06M | Sell |
157,100
-110,100
| -41% | -$1.63M | ﹤0.01% | 4874 |
|
|
2022
Q2 | $3.73M | Buy |
267,200
+128,100
| +92% | +$1.71M | ﹤0.01% | 3696 |
|
|
2022
Q1 | $2.07M | Buy |
139,100
+74,800
| +116% | +$1.02M | ﹤0.01% | 5393 |
|
|
2021
Q4 | $871K | Sell |
64,300
-70,500
| -52% | -$998K | ﹤0.01% | 7650 |
|
|
2021
Q3 | $2.09M | Sell |
134,800
-28,400
| -17% | -$480K | ﹤0.01% | 5732 |
|
|
2021
Q2 | $3.04M | Buy |
163,200
+11,800
| +8% | +$210K | ﹤0.01% | 4989 |
|
|
2021
Q1 | $2.69M | Buy |
151,400
+11,200
| +8% | +$197K | ﹤0.01% | 5213 |
|
|
2020
Q4 | $2.49M | Buy |
140,200
+14,300
| +11% | +$228K | ﹤0.01% | 4644 |
|
|
2020
Q3 | $1.75M | Buy |
125,900
+36,500
| +41% | +$536K | ﹤0.01% | 4880 |
|
|
2020
Q2 | $1.29M | Buy |
89,400
+23,900
| +36% | +$314K | ﹤0.01% | 5347 |
|
|
2020
Q1 | $715K | Buy |
65,500
+13,400
| +26% | +$247K | ﹤0.01% | 6140 |
|
|
2019
Q4 | $1.11M | Sell |
52,100
-56,800
| -52% | -$1.27M | ﹤0.01% | 5320 |
|
|
2019
Q3 | $2.5M | Buy |
108,900
+66,900
| +159% | +$1.43M | ﹤0.01% | 3786 |
|
|
2019
Q2 | $827K | Sell |
42,000
-63,400
| -60% | -$1.24M | ﹤0.01% | 6127 |
|
|
2019
Q1 | $2.38M | Sell |
105,400
-54,200
| -34% | -$1.03M | ﹤0.01% | 3490 |
|
|
2018
Q4 | $3.6M | Buy |
159,600
+59,000
| +59% | +$1.19M | ﹤0.01% | 2684 |
|
|
2018
Q3 | $2.34M | Buy |
100,600
+40,400
| +67% | +$915K | ﹤0.01% | 3744 |
|
|
2018
Q2 | $1.32M | Buy |
60,200
+22,100
| +58% | +$432K | ﹤0.01% | 4787 |
|
|
2018
Q1 | $672K | Sell |
38,100
-53,400
| -58% | -$941K | ﹤0.01% | 6047 |
|
|
2017
Q4 | $1.72M | Buy |
91,500
+16,500
| +22% | +$328K | ﹤0.01% | 4181 |
|
|
2017
Q3 | $1.65M | Buy |
75,000
+21,400
| +40% | +$483K | ﹤0.01% | 4275 |
|
|
2017
Q2 | $1.29M | Buy |
53,600
+32,100
| +149% | +$816K | ﹤0.01% | 4732 |
|
|
2017
Q1 | $600K | Sell |
21,500
-13,300
| -38% | -$349K | ﹤0.01% | 6160 |
|
|
2016
Q4 | $850K | Buy |
34,800
+14,300
| +70% | +$328K | ﹤0.01% | 5870 |
|
|
2016
Q3 | $516K | Sell |
20,500
-6,600
| -24% | -$158K | ﹤0.01% | 6002 |
|
|
2016
Q2 | $559K | Buy |
+27,100
| New | +$565K | ﹤0.01% | 5935 |
|
|
2015
Q3 | – | Sell |
-7,800
| Closed | -$201K | – | 10106 |
|
|
2015
Q2 | $201K | Buy |
+7,800
| New | +$221K | ﹤0.01% | 9282 |
|
|
2014
Q4 | – | Sell |
-9,300
| Closed | -$226K | – | 10025 |
|
|
2014
Q3 | $226K | Buy |
+9,300
| New | +$258K | ﹤0.01% | 8473 |
|
Other funds holding SBRA
VPM
VCM
N
Susquehanna International Group's SBRA Position: Q1 2026 in Review
Susquehanna International Group increased its Sabra Healthcare REIT (SBRA) stake by 1,107% in Q1 2026, buying an estimated $2.93M and bringing the position to 162,436 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #5194.
Susquehanna International Group first reported a position in SBRA in Q4 2013 and has held it in 41 quarters since. The position peaked at $5.3M in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Susquehanna International Group held 162,436 shares of Sabra Healthcare REIT worth $3.12M as of Q1 2026.
- Susquehanna International Group bought 148,977 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.93M.
- Sabra Healthcare REIT made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5194 holding.
- Susquehanna International Group first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 41 quarters since.
- Susquehanna International Group's Sabra Healthcare REIT position peaked at $5.3M in Q2 2025.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.